Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery?

J Ethnopharmacol. 2019 Mar 1:231:409-428. doi: 10.1016/j.jep.2018.11.016. Epub 2018 Nov 12.

Abstract

Ethnopharmacological relevance: In Traditional Oriental Medicine (TOM), the development of hearing pathologies is related to an inadequate nourishment of the ears by the kidney and other organs involved in regulation of bodily fluids and nutrients. Several herbal species have historically been prescribed for promoting the production of bodily fluids or as antiaging agents to treat deficiencies in hearing.

Aim of review: The prevalence of hearing loss has been increasing in the last decade and is projected to grow considerably in the coming years. Recently, several herbal-derived products prescribed in TOM have demonstrated a therapeutic potential for acquired sensorineural hearing loss and tinnitus. Therefore, the aims of this review are to provide a comprehensive overview of the current known efficacy of the herbs used in TOM for preventing different forms of acquired sensorineural hearing loss and tinnitus, and associate the traditional principle with the demonstrated pharmacological mechanisms to establish a solid foundation for directing future research.

Methods: The present review collected the literature related to herbs used in TOM or related compounds on hearing from Chinese, Korean, and Japanese herbal classics; library catalogs; and scientific databases (PubMed, Scopus, Google Scholar; and Science Direct).

Results: This review shows that approximately 25 herbal species and 40 active compounds prescribed in TOM for hearing loss and tinnitus have shown in vitro or in vivo beneficial effects for acquired sensorineural hearing loss produced by noise, aging, ototoxic drugs or diabetes. The inner ear is highly vulnerable to ischemia and oxidative damage, where several TOM agents have revealed a direct effect on the auditory system by normalizing the blood supply to the cochlea and increasing the antioxidant defense in sensory hair cells. These strategies have shown a positive impact on maintaining the inner ear potential, sustaining the production of endolymph, reducing the accumulation of toxic and inflammatory substances, preventing sensory cell death and preserving sensory transmission. There are still several herbal species with demonstrated therapeutic efficacy whose mechanisms have not been deeply studied and others that have been traditionally used in hearing loss but have not been tested experimentally. In clinical studies, Ginkgo biloba, Panax ginseng, and Astragalus propinquus have demonstrated to improve hearing thresholds in patients with sensorineural hearing loss and alleviated the symptoms of tinnitus. However, some of these clinical studies have been limited by small sample sizes, lack of an adequate control group or contradictory results.

Conclusions: Current therapeutic strategies have proven that the goal of the traditional oriental medicine principle of increasing bodily fluids is a relevant approach for reducing the development of hearing loss by improving microcirculation in the blood-labyrinth barrier and increasing cochlear blood flow. The potential benefits of TOM agents expand to a multi-target approach on different auditory structures of the inner ear related to increased cochlear blood flow, antioxidant, anti-inflammatory, anti-apoptotic and neuroprotective activities. However, more research is required, given the evidence is very limited in terms of the mechanism of action at the preclinical in vivo level and the scarce number of clinical studies published.

Keywords: Allylmercaptocysteine; Astragaloside IV; Baicalein; Catalpol; Celastrol; Cochlear blood flow; Compound K; Curculigosides; Curcumin; Diabetic hearing loss; Diallyl disulfide; Dieckol, eckol phlorofurofu-coeckol A; Dioscin; Diosmin; Epicatechin; Epigallocatechin-3-gallate; Galangin; Ginkgolide B; Ginsenosides Rg1, Rb1, Rb2, Re; Hair cell death; Hesperetin; Hesperidin; Isorhamnetin; Kaempferol; Lecithin; Luteolin; Morin; Naringin; Noise-induced hearing loss; Ototoxicity; Presbycusis; Puerarin; Quercetin; Resveratrol; Rosmarinic acid; S-allylcysteine; Silybin, Silydianin, Silychristin; Tanshinone IIA; Ursolic acid; β--conglycinin.

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Discovery
  • Ethnopharmacology
  • Hearing Loss, Sensorineural / drug therapy*
  • Hearing Loss, Sensorineural / epidemiology
  • Hearing Loss, Sensorineural / metabolism
  • Hearing Loss, Sensorineural / physiopathology
  • Humans
  • Medicine, East Asian Traditional*